Company: EQS
Filing Date: 2025-04-10
Form Type: 10-K
Source: 0001712543-25-000016
Chunk: 20

Company: EQUUS TOTAL RETURN, INC.
Filing Date: 2025-04-10
Form: 10-K
Item: Item 2
Chunk 20
---
 record transfers of our shares, maintain proxy records and to process distributions. The principal
business office of our transfer agent is 6201 15th Avenue, 2nd Floor, Brooklyn, NY 11219.

Certifications

In July
2024, pursuant to Section 303A.12(a) of the NYSE Listed Company Manual, we submitted to the NYSE an unqualified certification of our Chief
Executive Officer. In addition, certifications by our Chief Executive Officer and Chief Financial Officer have been filed as exhibits
to this annual report on Form 10-K as required by the Securities Exchange Act of 1934, as amended, and the Sarbanes-Oxley Act of 2002.

Forward-Looking Statements

All statements
contained herein that are not historical facts including, but not limited to, statements regarding anticipated activity are “forward-looking
statements” within the meaning of the federal securities laws, involve a number of risks and uncertainties, and are based on the
beliefs and assumptions of Management, based on information currently available to Management. Actual results may differ materially. In
some cases, readers can identify forward- looking statements by words such as “may,” “will,” “should,”
“expect,” “objective,” “plan,” “intend,” “anticipate,” “believe,”
“ Management believes,” “estimate,” “predict,” “project,” “potential,” “forecast,”
“continue,” “strategy,” or “position” or the negative of such terms or other variations of them or
by comparable terminology. In particular, statements, express or implied, concerning future actions, conditions, or events, future operating
results, or the ability to generate sales, income, or cash flow are forward-looking statements.

Among the
factors that could cause actual results to differ materially are the following: (i) changes in the economic conditions in which we operate,
including changes related to the evolving impact of the coronavirus, which might negatively impacting our financial resources; (ii) the
substantially greater resources of certain of our competitors than the Fund, potentially reducing the number of suitable investment opportunities
offered or reducing the yield necessary to consummate the investment; (iii) the uncertainty regarding the value of our privately held
securities that require a good faith estimate of fair value for which a change in estimate could affect the Fund’s net asset value;
(iv) the illiquidity of our investments in securities of privately held companies which could affect our ability to realize a gain